Hasil Filter

1977

Total database: 17430
Struktur (SMILES)
1074 (54.3%)
Target
1046 (52.9%)
Genomik
39 (2.0%)
Referensi
1977 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (1977)

Halaman 9 / 40
Corcorus capsularis fiber Approved DB10711
biotech

Corcorus capsularis fiber is used in allergenic testing.

Kategori:
Cell-mediated ImmunityIncreased Histamine ReleaseIncreased IgG Production +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Corifollitropin alfa Approved DB09066
biotech | CAS: 195962-23-3

Corifollitropin alfa, also known as _Elonva_ is used in women undergoing fertility treatment to stimulate the development of more than one mature egg (oocyte) at a time in the ovaries. This drug used together with _a gonadotropin-releasing hormone (GnRH) anta…

Kategori:
Drugs that are Mainly Renally ExcretedFollicle Stimulating HormoneGenito Urinary System and Sex Hormones +9
Target Protein:
Follicle-stimulating hormone receptor
Waktu ParuhCorifollitropin alf…
Vol. DistribusiDistribution, metab…
Klirens0.13 L/h (0.10-0.18…
Genetik -
biotech

The Coronavirus-Like Particle COVID-19 Vaccine is in development and testing through Meidcago in Quebec City, Canada. The vaccine was developed by creating SARS-Cov-2 virus-like particles (CoVLPs), which mimic the structure of the virus without carrying the g…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech | CAS: 121249-14-7

Corticorelin, available commercially as corticorelin ovine triflutate (tradename Acthrel), is a synthetic form of the peptide human corticotropin-releasing hormone (hCRH), a potent stimulator of adrenocorticotropic hormone (ACTH) release from the anterior pit…

Kategori:
Amino Acids, Peptides, and ProteinsDiagnostic AgentsHormones +9
Target Protein:
Corticotropin-releasing factor receptor 1Corticotropin-releasing factor receptor 2
Waktu ParuhPlasma half-lives f…
Vol. DistribusiThe mean volume of …
Klirens95 ± 11 L/m2/day
Genetik -
Cortisone acetate Approved DB01380
small molecule | CAS: 50-04-4

Cortisone acetate was first isolate in 1935 and became more widely researched in 1949.[A226295] Since then, glucocorticoids such as cortisone acetate have been used to treat a number of inflammatory conditions such as endocrine, rheumatic, collagen, dermatolo…

Kategori:
17-HydroxycorticosteroidsAdrenal Cortex HormonesAdrenals +25
Target Protein:
Steroid hormone receptor ERR2Estrogen-related receptor gammaGlucocorticoid receptor +2
Waktu Paruh-
Vol. Distribusi-
KlirensData regarding the …
Genetik -
Cortivazol DB13003
small molecule | CAS: 1110-40-3

Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).

Kategori:
Adrenal Cortex HormonesAnti-Inflammatory AgentsCorticosteroids +15
Target Protein:
Glucocorticoid receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cotadutide DB15194
small molecule | CAS: 1686108-82-6

Cotadutide is under investigation in clinical trial NCT03444584 (Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Subject With Type 2 Diabetes).

Kategori:
Amino Acids, Peptides, and Proteins
Target Protein:
Pro-glucagon
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Covax-19™ DB15846
biotech

Covax-19™, a protein-based vaccine, was developed through partnership between APC and Vaxine. It uses an insect-cell-produced recombinant SARS-CoV-2 spike protein and Vaxine’s adjuvant, Advax-SM. This adjuvant is designed to circumvent high fevers, fatigue, a…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony stimulating factor (GM-CSF), a cytokine known to enhanc…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

COVID-19 Spike-GM-CSF Protein Lactated Ringer's Injection is an intradermal injection currently being investigated in the clinical trial NCT03348670 (Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP) (AP-TP-…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Dendritic cells (DCs) can be derived and differentiated from peripheral blood mononuclear cells in the presence of specific cytokines and growth factors. These cells are then loaded with antigens produced by a virus or tumor cell and administered as a vaccine…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CP-601927 DB12244
small molecule | CAS: 357425-02-6

CP-601,927 has been used in trials studying the basic science and treatment of Major Depressive Disorder.

Target Protein:
Neuronal acetylcholine receptor subunit alpha-4Neuronal acetylcholine receptor subunit beta-2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CP-778875 DB19211
small molecule | CAS: 866355-28-4

CP-778875 is under investigation in clinical trial NCT00326326 (Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.).

Kategori:
Acids, CarbocyclicAmidesBenzene Derivatives +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CPD 923 DB05856
small molecule

CPD 923 (N-butylgalactonorjirimycin) is an iminosugar and an analogue of ZavescaTM. It shows efficacy in vivo studies, as well as a favourable pre-clinical tolerability profile.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CPGJ602 DB17485
biotech

CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 6903-79-3

COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.

Kategori:
Cardiac Therapy
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Each year it is estimated there are 45,000 snakebites in the US and 300,000 to 400,000 bites worldwide. About 8000 of these snakebites involve venomous snake species. The majority of people bitten are males and about 50% occur in the age group of 18 to 28 [F1…

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Target Protein:
Group 10 secretory phospholipase A2
Waktu Paruh12 to 23 hours [FDA…
Vol. Distribusi-
KlirensThis product was sh…
Genetik -
Crotalus atrox antivenin Approved DB13892
biotech

Each year it is estimated there are 45,000 snakebites in the US and 300,000 to 400,000 bites worldwide. About 8000 of these snakebites involve venomous snake species. The majority of people bitten are males and about 50% occur in the age group of 18 to 28 [F1…

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Waktu Paruh12-23 hours [F113]
Vol. Distribusi-
Klirens-
Genetik -
biotech

Crotalus scutulatus antivenin is derived and purified immunoglobulin fragments obtained from other domestic animals such as sheep previously immunized with Crotalus scutulatus (also known as the _Mojave rattlesnake_ [L2856]). The final purified antivenin …

Kategori:
AntiveninsPassively Acquired ImmunityVenom Neutralization
Waktu ParuhApproximately 15 ho…
Vol. Distribusi0.3 L/kg [FDA label]
Klirens32 mL/min (approxim…
Genetik -
Crovalimab Approved DB16128
biotech | CAS: 1917321-26-6

Crovalimab is a humanized monoclonal antibody and complement C5 inhibitor.[L50908] It consists of two heavy chains (451 amino acid residues each) and two light chains (217 amino acid residues each).[L50908] First developed by Chugai Pharmaceutical, in collabo…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodies, MonoclonalAntineoplastic and Immunomodulating Agents +7
Target Protein:
Complement C5
Waktu ParuhThe mean estimated …
Vol. DistribusiThe mean central an…
KlirensIn PNH treatment-na…
Genetik -
CRx-401 DB05775
small molecule

CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol a…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

Deskripsi belum tersedia.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Culex pipiens Approved DB14165
biotech

Culex pipiens allergenic extract is used in allergenic testing.

Kategori:
Non-Standardized Insect Allergenic Extract
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cupric Chloride Approved DB09131
small molecule | CAS: 7447-39-4

Cupric chloride, for injection, is a sterile, nonpyrogenic solution intended for use as an additive to solutions for Total Parenteral Nutrition (TPN).

Kategori:
ElementsMetalsMetals, Heavy +1
Target Protein:
Vitamin K-dependent protein CCystatin-B
Waktu Paruh-
Vol. DistribusiCopper is distribut…
Klirens-
Genetik -
Curcuma aromatica root oil Approved DB11301
biotech | CAS: 94349-73-2

Curcuma aromatica root oil is obtained from the roots of *Curcuma aromatica*, or more commonly called wild tumeric, via steamed distillation. *Curcuma aromatica* belongs to the family Zingiberaceae. The wild ginger has been used as a cosmetic herbal where its…

Kategori:
Biological ProductsPlant OilsPlant Preparations
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
biotech

_Curcuma xanthorrhiza_ oil is extracted from _Curcuma xanthorrhiza_ Roxb., a member of the ginger family (_Zingiberaceae_) that is widely distributed in the region of Southeastern Asia [A33162]. _Curcuma xanthorrhiza_ is also known as Javanese Turmeric or Te…

Waktu ParuhThere are no pharma…
Vol. DistribusiThere are no pharma…
KlirensThere are no pharma…
Genetik -
CV-8102 DB19184
biotech

CV-8102 is under investigation in clinical trial NCT03203005 (IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CVnCoV DB15844
biotech

The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, …

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CVnCoV Vaccine DB15843
biotech

The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, …

Kategori:
Amino Acids, Peptides, and ProteinsAntigensBiological Factors +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CX-2009 DB16090
biotech | CAS: 2145115-85-9

CX-2009 is under investigation in clinical trial NCT03149549 (PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
CX501 DB05174
small molecule

Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of the oesophagus. It is developed by Cellerix and is in phas…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cyanocobalamin Approved DB00115
small molecule | CAS: 68-19-9

Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria [A175276], and is necessary for DNA synthesis and cellular e…

Kategori:
Antianemic PreparationsBlood and Blood Forming OrgansCorrinoids +10
Target Protein:
Methionine synthaseMethylmalonyl-CoA mutase, mitochondrialMethionine synthase reductase +3
Waktu ParuhApproximately 6 day…
Vol. DistribusiCobalamin is distri…
KlirensDuring vitamin load…
Genetik -
Cyclobenzaprine Approved DB00924
small molecule | CAS: 303-53-7

Cyclobenzaprine, a centrally-acting muscle relaxant, was first synthesized in 1961[A185039] and has been available for human use since 1977.[A184982] It was initially studied for use as antidepressant given its structural similarity to tricyclic antidepressan…

Kategori:
Agents that reduce seizure thresholdAntidepressive AgentsBenzocycloheptenes +23
Target Protein:
Alpha-2C adrenergic receptor5-hydroxytryptamine receptor 2A5-hydroxytryptamine receptor 2B +7
Waktu ParuhThe effective half-…
Vol. DistribusiThe volume of distr…
KlirensThe approximate pla…
Genetik -
Cyclosporine Approved DB00091
small molecule | CAS: 59865-13-3

Cyclosporine is a calcineurin inhibitor known for its immunomodulatory properties that prevent organ transplant rejection and treat various inflammatory and autoimmune conditions. It is isolated from the fungus _Beauveria nivea_.[A174049] Initially manufactur…

Kategori:
Agents causing hyperkalemiaAgents Causing Muscle ToxicityAgents that produce hypertension +45
Target Protein:
Guided entry of tail-anchored proteins factor CAMLGProtein phosphatase 3 catalytic subunit alphaCalcineurin subunit B type 2 +2
Waktu ParuhThe half-life of cy…
Vol. DistribusiThe distribution of…
KlirensCyclosporin shows a…
Genetik -
Cyclothiazide Approved DB00606
small molecule | CAS: 2259-96-3

As a diuretic, cyclothiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. Thiazides like cyclothiazide also inhibit sodium ion transport…

Kategori:
Antihypertensive AgentsCardiovascular AgentsDiuretics +11
Target Protein:
Sodium/potassium-transporting ATPase subunit gammaCarbonic anhydraseCarbonic anhydrase 2 +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Cystine Approved DB00138
small molecule | CAS: 56-89-3

A covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.

Kategori:
Amino AcidsAmino Acids, DiaminoAmino Acids, Dicarboxylic +12
Target Protein:
Cystine/glutamate transporterCystinosin
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
D-glucose Approved DB01914
small molecule | CAS: 50-99-7

Glucose is a simple sugar (monosaccharide) generated during phosynthesis involving water, carbon and sunlight in plants. It is produced in humans via hepatic gluconeogenesis and breakdown of polymeric glucose forms (glycogenolysis). It circulates in human cir…

Kategori:
CarbohydratesCompounds used in a research, industrial, or household settingDiet, Food, and Nutrition +11
Waktu ParuhThe approximate hal…
Vol. DistribusiThe mean volume of …
KlirensThe mean metabolic …
Genetik -
D-JNKI-1 DB05660
small molecule | CAS: 1198367-70-2

A synthetic, cell permeable peptide that blocks the MAPK-JNK signal pathway; has potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the organ of Corti during times of oxidative stress.

Kategori:
Amino Acids, Peptides, and ProteinsNeuroprotective Agents
Target Protein:
Mitogen-activated protein kinase 8Mitogen-activated protein kinase 9Mitogen-activated protein kinase 10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule | CAS: 10162-32-0

A pteridine derivative present in body fluids; elevated levels result from immune system activation, malignant disease, allograft rejection, and viral infections. (From Stedman, 26th ed) Neopterin also serves as a precursor in the biosynthesis of biopterin.

Kategori:
CoenzymesEnzymes and CoenzymesHeterocyclic Compounds, Fused-Ring +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
D3S-001 DB19008
small molecule | CAS: 2706637-43-4

D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.g12c Mutation).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
DA-8031 DB19024
small molecule | CAS: 1148027-74-0

DA-8031 is under investigation in clinical trial NCT01798667 (Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature Ejaculation).

Kategori:
Antidepressive AgentsCentral Nervous System DepressantsHeterocyclic Compounds, Fused-Ring +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Daclatasvir Approved DB09102
small molecule | CAS: 1009119-64-5

Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus (HCV) used for the treatment of chronic HCV genotype 1 and 3 infection. It is marketed under the name DAKLINZA and is contained in daily oral tablets as the hydrochloride salt form . Hep…

Kategori:
Acids, AcyclicAmino AcidsAmino Acids, Branched-Chain +21
Target Protein:
Genome polyproteinNonstructural protein 5A
Waktu ParuhFollowing multiple …
Vol. DistribusiThe approximate vol…
KlirensIn subjects who rec…
Genetik -
Daclizumab DB00111
biotech | CAS: 152923-56-3

Humanized IgG1 Mab that binds to the human interleukin-2 receptor (anti-Tac or anti-CD25). Daclizumab is a composite of human (90%) and murine (10%) antibody sequences. The human sequences were derived from the constant domains of human IgG1 and the variable …

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +17
Target Protein:
Interleukin-2 receptor subunit alphaInterleukin-2 receptor subunit betaLow affinity immunoglobulin gamma Fc region receptor III-B +9
Waktu Paruh11-38 days
Vol. Distribusi-
Klirens-
Genetik -
Dactinomycin Approved DB00970
small molecule | CAS: 50-76-0

A compound composed of a two cyclic peptides attached to a phenoxazine that is derived from streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a…

Kategori:
ActinomycinActinomycinesAmino Acids, Peptides, and Proteins +18
Target Protein:
DNADNA topoisomerase 2DNA topoisomerase 1
Waktu Paruh36 hours
Vol. Distribusi-
Klirens-
Genetik -
Dalfampridine Approved DB06637
small molecule | CAS: 504-24-5

Dalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. This is the first drug that was specifically approved to help with mobility in these patients. FDA approved on January 22, 2010.

Kategori:
AminesAminopyridinesCardiovascular Agents +12
Target Protein:
Potassium voltage-gated channel subfamily A member 1Potassium voltage-gated channel subfamily A member 2Potassium voltage-gated channel subfamily A member 3 +13
Waktu ParuhImmediate release f…
Vol. Distribusi10 mg extended rele…
Klirens-
Genetik -
Dalosirvat DB18960
small molecule | CAS: 1360540-81-3

Dalosirvat is under investigation in clinical trial NCT03742518 (A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Damoctocog alfa pegol Approved DB14700
biotech | CAS: 1363853-26-2

In recent years, various extended half-life factor VIII and factor IX preparations have been studied and gained approval. In order to extend half-lives, techniques such as fusion to protein conjugates (Fc part of IgG1 or albumin), chemical modification (PEGyl…

Kategori:
Blood Coagulation FactorsPegylated agents
Target Protein:
Coagulation factor VIII
Waktu Paruh18.6 ± 4.6h after a…
Vol. Distribusi-
Klirens142 ± 33 mL/h on wi…
Genetik -
Danaparoid Approved DB06754
small molecule | CAS: 308068-55-5

Danaparoid is a low-molecular-weight heparinoid with an average molecular weight of 5500 Daltons consisting of a mixture of glycosaminoglycans [A32565]. The active constituents are heparan, dermatan and [DB09301] [T28], and they are isolated from the porcine …

Kategori:
Agents causing hyperkalemiaAnticoagulantsBlood and Blood Forming Organs +9
Target Protein:
Antithrombin-III
Waktu ParuhPharmacokinetic stu…
Vol. DistribusiPharmacokinetic stu…
KlirensPharmacokinetic stu…
Genetik -
Danicopan Approved DB15401
small molecule | CAS: 1903768-17-1

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematologic disease characterized by hemolysis, thrombophilia, and bone marrow dysfunction.[A263501,L50417] Both hemolysis and thrombophilia are mediated primarily by the complement system.[A263501]…

Kategori:
AminesAmino AcidsAmino Acids, Cyclic +10
Target Protein:
Complement factor D
Waktu ParuhThe mean half-life …
Vol. DistribusiThe apparent volume…
KlirensThe mean apparent c…
Genetik -
Dapagliflozin Approved DB06292
small molecule | CAS: 461432-26-8

Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, and it was the first SLGT2 inhibitor to be approved. indicated for managing diabetes mellitus type 2.[A261596] When combined with diet and exercise in adults, dapagliflozin helps to improve …

Kategori:
Alimentary Tract and MetabolismBenzene DerivativesBlood Glucose Lowering Agents +19
Target Protein:
Sodium/glucose cotransporter 2
Waktu ParuhThe mean plasma ter…
Vol. DistribusiThe volume of distr…
KlirensOral plasma clearan…
Genetik -
Menampilkan 401–450 dari 1977
Sebelumnya Halaman 9 / 40 Berikutnya